Edesa Biotech Publishes Phase 2 Substudy Results of ARDS Drug Candidate
Go back to Edesa Biotech Publishes Phase 2 Substudy Results of ARDS Drug Candidate| (NASDAQ: EDSA) | Delayed: 3.86 -0.15 (3.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.01 | 52 Week High | $ | |||
| Open | $4.01 | 52 Week Low | $ | |||
| Day High | $4.01 | P/E | N/A | |||
| Day Low | $3.81 | EPS | $ | |||
| Volume | 18,455 | |||||
